Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Healthy volunteers or Chronic Kidney Disease (CKD) patients with clinically indicated renal biopsy.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
186 participants in 2 patient groups
Loading...
Central trial contact
Bobbie Ott
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal